The Immunology of Endometriosis and the Therapeutic Potential of Bispecific Antibodies: A Hypothesis
article
OA: closed
CC0
Abstract
Endometriosis is a chronic inflammatory disease characterized by the presence of endometrial lesions outside the uterus. Current treatment methods primarily focus on hormone-based therapy or invasive procedures. However, given the crucial role of the immune system in disease initiation and progression, there is an opportunity to explore new treatment approaches. Bispecific antibodies, which bind two different cells using their bivalent arms, have shown promise in treating cancers and autoimmune diseases. This study postulates that, due to the similarities in pathogenesis between endometriosis and the aforementioned diseases, a novel therapeutic method based on this new target could be introduced. This approach could potentially lead to a reduction in the limitations to patients' quality of life. In addition, it is important to highlight that future studies should prioritize the identification of specific binding markers on endometrial cells. This could contribute to the development of new diagnostic tools for the disease. Furthermore, the production of bispecific antibodies that selectively bind to these receptors on immune cells may prove effective in improving the immune response.
Full text
1,662 characters
· extracted from
oa-doi-fallback
· click to expand
Publication
Academic Journal of Surgery
Record type
Journal article
Published
3 January 2025
Authors
Mahdi Mohseni | Manouchehr Nasrollahzadeh Saravi | Iman Menbari Oskouie | Masoumeh Majidi Zolbin
The publisher of this work supports multiple
resolution. The work is available from the following locations:
{'doi': '10.18502/ajs.v7i4.17468', 'member_id': '7770', 'member': 'Knowledge E DMCC', 'container-title': 'Academic Journal of Surgery', 'primary-resource': 'https://publish.kne-publishing.com/index.php/AJS/article/view/17468', 'tld': 'kne-publishing.com', 'clearbit-logo': '/static/no_logo.svg', 'coaccess': [], 'multiple-resolution': [{'url': 'https://ajs.tums.ac.ir/index.php/ajs/article/view/280', 'tld': 'tums.ac.ir', 'clearbit-logo': '/static/no_logo.svg'}], 'type': 'JOURNAL ARTICLE', 'published_date': '3 January 2025', 'publication': 'Academic Journal of Surgery', 'title': 'The Immunology of Endometriosis and the Therapeutic Potential of Bispecific Antibodies: A Hypothesis', 'name': None, 'id': None, 'location': None, 'display_doi': 'https://doi.org/10.18502/ajs.v7i4.17468', 'grant_info': None, 'grant_info_funders': None, 'grant_info_funder_ids': '', 'grant_info_type': None, 'multiple_lead_investigators': [], 'multiple_co_lead_investigators': [], 'multiple_investigators': [], 'finances': [], 'project_description': None, 'award_amount': None, 'award_start': None, 'funding_scheme': None, 'internal_award_number': None, 'editors': None, 'authors': 'Mahdi Mohseni | Manouchehr Nasrollahzadeh Saravi | Iman Menbari Oskouie | Masoumeh Majidi Zolbin', 'chairs': None, 'supplementary_ids': None}
https://doi.org/10.18502/ajs.v7i4.17468
JSON
XML
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-19T06:23:00.919175+00:00
License: CC0
· commercial use OK